Johnson & Johnson is a healthcare company focused on Innovative Medicine (pharmaceuticals) and MedTech following the separation of its consumer-health business. Drug pipeline, patent exposure, and litigation are key watch items.
With Secaura, you can ask any question about Johnson & Johnson's SEC filings and financials and get a cited, source-backed answer in seconds — grounded in real filings, never hallucinated.
How does J&J split revenue between Innovative Medicine and MedTech?
What patent expirations does Johnson & Johnson flag as risks?
What does J&J disclose about ongoing litigation?
How has J&J's free cash flow and dividend trended?
What are the growth drivers in J&J's MedTech segment?
What are the key risk factors in J&J's 10-K?
SEC filing Q&A
Ask about the 10-K, 10-Q, and 8-K — every answer cites the exact filing section it came from.
5-year XBRL financials
Revenue, margins, EPS, cash flow, CapEx and more, with year-over-year change indicators.
Institutional ownership
Form 13F holdings — see which institutions are building or trimming positions.
Insider transactions
Form 4 filings — track buying and selling by executives and directors.
Competitive-moat signals
Computed indicators of durable competitive advantage, grounded in the filings.
Open Secaura, select JNJ, and ask in plain English — for example "How does J&J split revenue between Innovative Medicine and MedTech?". Secaura retrieves the exact sections of JNJ's 10-K and 10-Q filings and returns a cited answer you can verify against the source.
Secaura surfaces JNJ institutional ownership from Form 13F filings and insider transactions from Form 4 filings, alongside its SEC filing Q&A — so you can review who is buying and selling in one place.
Five years of XBRL financial metrics — revenue, margins, EPS, cash flow, and more — plus JNJ's 10-K, 10-Q, and 8-K filings, institutional and insider activity, and competitive-moat signals. Answers are grounded in real filings, never hallucinated.
Yes. JNJ is available on the free tier, which includes cited SEC filing Q&A, five-year financials, and ownership data, with a daily question limit. Sign in with Google to start.
Ask Secaura about Johnson & Johnson
Cited answers from real SEC filings. Free to start — no credit card.
Try it free